Inmunohistochemical expression of thymidilate synthase, ERCC1, pKDR, and LDH5 as predcitive markers of efficacy in patients with advanced colon cancer treated with XELOX or FOLFOX with or without bevacizumab.
Javier Garde
No relevant relationships to disclose
Elena Evgenyeva
No relevant relationships to disclose
Gil raga Mireia
No relevant relationships to disclose
Laia Bernet
No relevant relationships to disclose
Asuncion Juarez
No relevant relationships to disclose
Juan Laforga
No relevant relationships to disclose
Juan Manuel Gassent
No relevant relationships to disclose
Martin Demarchi
No relevant relationships to disclose
Carlos Camps
No relevant relationships to disclose
Antonio Llombart
No relevant relationships to disclose